NVCT Nuvectis Pharma, Inc.: institutional ownership and insider trading
89 funds reported holding $208M of Nuvectis Pharma, Inc. in their latest 13F filings; in Q2 2026 funds net bought $113M, with 28 new positions and 6 funds selling out; over the last 12 months insiders bought $1.79M and sold $0 on the open market.
Famous investors holding NVCT
- Ken Griffin (Citadel Advisors): $3.35M, 0.0% of the portfolio
Largest institutional holders of NVCT
- TANG CAPITAL MANAGEMENT LLC — $28.5M
- BlackRock, Inc. (BLK) — $18.4M
- Soleus Capital Management, L.P. — $18.4M
- PERCEPTIVE ADVISORS LLC — $18.4M
- IRIDIAN ASSET MANAGEMENT LLC/CT — $16.8M
- VANGUARD CAPITAL MANAGEMENT LLC — $16.0M
- BALDWIN WEALTH PARTNERS LLC/MA — $8.07M
- GEODE CAPITAL MANAGEMENT, LLC — $7.95M
- Occam Crest Management LP — $7.39M
- SPHERA FUNDS MANAGEMENT LTD. — $7.04M
Recent NVCT insider trades
- Jun 30, 2026: Bentsur Ron bought 12,500 shares ($250K)
- Jun 30, 2026: Mosseri Marlio Charles bought 50,000 shares ($916K)
- Nov 5, 2025: Kaplan Matthew L. bought 11,000 shares ($64.2K)
- Nov 5, 2025: Sanchez Juan bought 13,000 shares ($75.3K)
5%+ owners
- Soleus Capital Management, L.P.: 5.1% (Schedule 13G, filed Aug 6, 2026)